The Leukemia & Lymphoma Society of Canada is proud to be able to commit funds to Canadian Translational Research Program grants awarded by The Leukemia & Lymphoma Society (LLS).
The Translational Research Program (TRP) puts you on the bench-to-bedside fast track when it comes to finding better treatment and cures for blood cancers. The Leukemia & Lymphoma Society funds new and innovative research that shows high promise for translating basic biomedical knowledge to clinical application.
LLSC is partnering with The Leukemia & Lymphoma Society (LLS-US) to advance our common mission to find cures for blood cancers and improve the quality of life of patients and their families. LLS-US and LLSC will jointly fund up to three (3) meritorious TRP applications focused on blood cancer research from investigators working in Canada.
Applications must be submitted to the LLS TRP program and will be evaluated within the general pool of TRP applications. Applications will be jointly reviewed by LLS and LLSC and scientific progress of each awarded TRP will be evaluated by both organizations on an annual basis. LLS will administer the grant program.
Key dates for 2022-2023
- Call for Proposals - August 29, 2022
- Letter of Intent (LOI) due - October 28, 2022
- Full application deadline - January 16, 2023
- Notification of Awards - May, 2023
- Award Start Date - July 1, 2023